Safety and Effectiveness of Hydroxychloroquine and Azithromycin Combination Therapy for Treatment of Hospitalized Patients with COVID-19: A Propensity-Matched Study.

Henry D HuangHani JneidMariam AzizVenkatesh RaviParikshit S SharmaTimothy LarsenNeal ChatterjeeBasil SaourZaid AzizHemal NayakRichard G TrohmanKousik Krishnan

Published in: Cardiology and therapy (2020)

In this propensity-matched study, there was no difference in in-hospital mortality, life-threatening arrhythmias, or incidence of PEA arrest between the HCQ-AZM and untreated control groups. QTc intervals were longer in patients receiving HCQ-AZM, but only one patient developed drug-related ventricular tachycardia.

Keyphrases

combination therapy
randomized controlled trial
systematic review
emergency department
cell cycle
congenital heart disease
drug induced